Over the last several years, the pharmaceutical and healthcare organizations have developed a strong interest toward applying artificial intelligence (AI) in various areas, ranging from medical image analysis and elaboration of electronic health records (EHRs) to more basic research like building disease ontologies, preclinical drug discovery, and clinical trials. The demand for the ML/AI technologies, as well as for ML/AI talent, is growing in the pharmaceutical and healthcare industries and driving the formation of a new interdisciplinary industry (‘data-driven healthcare’).
Forbes Article link: https://www.forbes.com/sites/yiannismouratidis/2019/02/13/the-100-leading-pioneers-of-ai-drug-development/amp/
